Healthy Extracts (HYEX) Cash from Financing Activities (2015 - 2025)
Healthy Extracts (HYEX) posted quarterly Cash from Financing Activities of -$486274.0 for Q4 2025, down 1506.99% year-over-year from $34561.4 in Q4 2024, and down 280.89% quarter-over-quarter from $268829.0 in Q3 2025.
Healthy Extracts (HYEX) Cash from Financing Activities (2015 - 2025) Analysis & Trends
Healthy Extracts' Cash from Financing Activities history runs 11 years deep, the most recent figure standing at -$486274.0 for Q4 2025.
- In Q4 2025, Cash from Financing Activities fell 1506.99% year-over-year to -$486274.0; the TTM figure through Dec 2025 stood at -$186906.0 (up 1.31% YoY), while the FY2025 annual figure was -$186906.0, up 1.31% from the prior year.
- Cash from Financing Activities for Q4 2025 stood at -$486274.0, down from $268829.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $846880.0 in Q1 2021, with the low at -$486274.0 in Q4 2025.
- The 5-year median for Cash from Financing Activities is $35458.5 (2023), against an average of $69648.0.
- The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities soared 3755.28% in 2023, then tumbled 1506.99% in 2025.
- Healthy Extracts' Cash from Financing Activities stood at $77199.0 in 2021, then soared by 79.7% to $138730.0 in 2022, then tumbled by 159.52% to -$82574.0 in 2023, then soared by 63.35% to -$30260.0 in 2024, then sank by 1506.99% to -$486274.0 in 2025.
- Business Quant data shows HYEX's Cash from Financing Activities at -$486274.0 in Q4 2025, $268829.0 in Q3 2025, and $83782.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -1.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -813.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -1.13 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 122.40 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -1.24 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 63.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -74.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Healthy Extracts | 19.12 Mn | 18.93 Mn | 1.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -486,274.00 |
| Dec 31, 2025 | -486,274.00 |
| Sep 30, 2025 | 268,829.00 |
| Sep 30, 2025 | 268,829.00 |
| Jun 30, 2025 | 83,782.00 |
| Jun 30, 2025 | 83,782.00 |
| Mar 31, 2025 | -53,243.00 |
| Mar 31, 2025 | -53,243.00 |
| Dec 31, 2024 | -30,260.00 |
| Dec 31, 2024 | -30,260.00 |
| Sep 30, 2024 | -100,109.00 |
| Sep 30, 2024 | -100,109.00 |
| Jun 30, 2024 | -108,166.00 |
| Jun 30, 2024 | -108,166.00 |
| Mar 31, 2024 | 49,146.00 |
| Mar 31, 2024 | 49,146.00 |
| Dec 31, 2023 | -82,574.00 |
| Dec 31, 2023 | -82,574.00 |
| Sep 30, 2023 | 21,771.00 |
| Sep 30, 2023 | 21,771.00 |